FDA approves heart catheter used with Stereotaxis system
The Food and Drug Administration has approved a heart catheter used with a Stereotaxis Inc. system to treat irregular heartbeats, the St. Louis-based surgical device company said today. It expects shipments to customers will begin in the next few weeks.
The device is called the Navistar RMT Thermocool Catherer and it is manufactured by Biosense Webster, Inc., a Johnson & Johnson company.
The catheter is used with Sterotaxis’ Niobe Remote Magnetic Navigation System to destroy tissue that disturbs normal heart rhythms.
"The magnetic irrigated catheter’s approval is the tipping point for Stereotaxis technology," Mike Kaminski, president and chief executive of the St no faxing 1 hour payday loans. Louis surgical device company, said in a press release. "We are confident that this product introduction will be transformative for our company."
Bloomberg reported that Johnson & Johnson will pay Stereotaxis a 15 percent royalty on the sale of each ThermoCool device, which cost $1,000 to $3,000 each.
gappleson@post-dispatch.com | Phone 314-340-8331